WELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing

Dow Jones

2025/03/31

By Adriano Marchese

WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies.

Shares fell over 24% to 3.77 Canadian dollars ($2.63).

The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings.

The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline.

Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors.

"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative," Krishnaratne said in a report.

WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

March 31, 2025 10:33 ET (14:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2523923646"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2523923646\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2523923646?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-31 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2523923646","market":"us","top_or_hot":-1,"title":"WELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre>\n \n</pre>\n<p>\n  WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies. \n</p>\n<p>\n  Shares fell over 24% to 3.77 Canadian dollars ($2.63). \n</p>\n<p>\n  The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings. \n</p>\n<p>\n  The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline. \n</p>\n<p>\n  Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors. \n</p>\n<p>\n  \"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative,\" Krishnaratne said in a report. \n</p>\n<p>\n  WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 31, 2025 10:33 ET (14:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWELL Health Technologies Shares Drop as U.S. Subsidiary Investigation Delays Full-Year Filing\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-03-31 22:33</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre>\n \n</pre>\n<p>\n  WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies. \n</p>\n<p>\n  Shares fell over 24% to 3.77 Canadian dollars ($2.63). \n</p>\n<p>\n  The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings. \n</p>\n<p>\n  The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline. \n</p>\n<p>\n  Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors. \n</p>\n<p>\n  \"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative,\" Krishnaratne said in a report. \n</p>\n<p>\n  WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 31, 2025 10:33 ET (14:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2523923646","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2523923646","pubTimestamp":1743431580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies.Shares fell over 24% to 3.77 Canadian dollars .The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings.The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline.Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors.\"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and dela","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","WELL":"WELLTOWER OP LLC","BK4203":"医疗保健房地产投资信托","BK4225":"医疗保健房地产信托"},"translate_title":"美国子公司调查推迟全年申报，WELL Health Technologies股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WELL":1},"content_text":"By Adriano Marchese \n\n\n \n\n\n  WELL Health Technologies fell sharply Monday morning after the company said that it will delay filing its year-end results due to complications with its U.S. subsidiary, Circle Medical Technologies. \n\n\n  Shares fell over 24% to 3.77 Canadian dollars ($2.63). \n\n\n  The Canadian digital health platform said late Friday that the subsidiary is being investigated by the U.S. Attorney's Office for the Northern District of California for how it handles its billings. \n\n\n  The company doesn't expect the resolution of the matter to have any material effect on its cash position or available resources, but said it doesn't expect to complete the statements for 2024 before a March 31 deadline. \n\n\n  Scotiabank analyst Kevin Krishnaratne thinks this won't be taken well by investors. \n\n\n  \"Although Circle Medical itself represents a smaller piece of the WELL story--about 13% of revenue and 6% of earnings before interest, taxes, depreciation and amortization through first nine months of 2024--we believe the news of an investigation and delay will nevertheless be viewed as negative,\" Krishnaratne said in a report. \n\n\n  WELL Health said it continues to look for strategic alternatives for Circle Medical and confirmed it is committed to carrying out this process in due course. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 10:33 ET (14:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}